Merck Announces Recipients of Third Annual €1 Million ‘Grant for Oncology Innovation’ Award

Grant recognizes pioneering research in personalized treatment of solid tumors

11-Oct-2016 - Denmark

Merck announced the recipients of the 2016 Grant for oncology Innovation (GOI), who will share a €1 million grant to progress their respective research initiatives. The winners were formally awarded at an award presentation coinciding with the 2016 annual European Society of Medical Oncology (ESMO) Congress in Copenhagen, Denmark.

The three winning proposals, which focus on breast cancer, colorectal cancer and lung cancer, were selected from a total of 405 applications representing 49 countries, following a comprehensive review by an expert scientific steering committee made up of internationally renowned oncologists.

The 2016 GOI winners are:

  • Alberto Bardelli, University of Torino, Italy, for his proposal: ‘Heterogeneity and clonal evolution as a therapeutic opportunity for colorectal cancers’
  • Enriqueta Felip, Vall d’Hebron Institute of Oncology, Spain, for her proposal: ‘New technologies for new treatments: liquid biopsy meets immunotherapy’
  • Dr Dongxu Liu, Auckland University of Technology, New Zealand for his proposal: ‘How does SHON* expression in tumors determine the efficacy of endocrine therapy in breast cancer

Other news from the department science

Most read news

More news from our other portals

Fighting cancer: latest developments and advances